$CYCN Insider Trading
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in Cyclerion Therapeutics, Inc..
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of all insider trading transactions in Cyclerion Therapeutics, Inc.. Get notifications about new insider transactions in Cyclerion Therapeutics, Inc. for free.
Page: 1
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Jun 28 2021 | CYCN | Cyclerion Therapeu ... | Isacson Ole | Option Exercise | A | 3.97 | 10,000 | 39,700 | 10,000 | ||
| Jun 28 2021 | CYCN | Cyclerion Therapeu ... | Churchwell Kevin | Option Exercise | A | 3.97 | 10,000 | 39,700 | 10,000 | ||
| Jun 28 2021 | CYCN | Cyclerion Therapeu ... | Mendelsohn Michael | Option Exercise | A | 3.97 | 10,000 | 39,700 | 10,000 | ||
| Jun 28 2021 | CYCN | Cyclerion Therapeu ... | CONRADES GEORGE H | Option Exercise | A | 3.97 | 10,000 | 39,700 | 10,000 | ||
| Jun 28 2021 | CYCN | Cyclerion Therapeu ... | DESOUZA ERROL B | Option Exercise | A | 3.97 | 10,000 | 39,700 | 10,000 | ||
| Jun 28 2021 | CYCN | Cyclerion Therapeu ... | MCGUIRE TERRANCE | Option Exercise | A | 3.97 | 10,000 | 39,700 | 10,000 | ||
| Jun 07 2021 | CYCN | Cyclerion Therapeu ... | MCGUIRE TERRANCE | Director | Buy | P | 3.12 | 3,322 | 10,365 | 24,957 | 21.6 K to 25 K (+15.35 %) |
| Jun 07 2021 | CYCN | Cyclerion Therapeu ... | MCGUIRE TERRANCE | Director | Buy | P | 3.12 | 92,831 | 289,633 | 697,313 | 604.5 K to 697.3 K (+15.36 %) |
| Jun 07 2021 | CYCN | Cyclerion Therapeu ... | Slate Path Capital LP | 10% Owner | Buy | P | 3.12 | 961,538 | 2,999,999 | 7,157,601 | 6.2 M to 7.2 M (+15.52 %) |
| May 10 2021 | CYCN | Cyclerion Therapeu ... | Hecht Peter M | Chief Executive Off ... | Buy | P | 2.43 | 302,000 | 733,860 | 1,224,528 | 922.5 K to 1.2 M (+32.74 %) |
| May 06 2021 | CYCN | Cyclerion Therapeu ... | Hecht Peter M | Chief Executive Off ... | Buy | P | 2.53 | 398,001 | 1,006,943 | 922,528 | 524.5 K to 922.5 K (+75.88 %) |
| May 06 2021 | CYCN | Cyclerion Therapeu ... | Hecht Peter M | Chief Executive Off ... | Buy | P | 2.29 | 300,000 | 687,000 | 524,527 | 224.5 K to 524.5 K (+133.61 %) |
| Mar 01 2021 | CYCN | Cyclerion Therapeu ... | Wright Christopher I | Chief Medical Offic ... | Sell | S | 3.99 | 2,637 | 10,522 | 42,728 | 45.4 K to 42.7 K (-5.81 %) |
| Dec 30 2020 | CYCN | Cyclerion Therapeu ... | Currie Mark G | President and CSO | Sell | S | 3.01 | 20,107 | 60,522 | 251,648 | 271.8 K to 251.6 K (-7.40 %) |
| Nov 12 2020 | CYCN | Cyclerion Therapeu ... | Busch Andreas | Chief Innovation Of ... | Buy | P | 2.53 | 125,000 | 316,250 | 254,704 | 129.7 K to 254.7 K (+96.37 %) |
| Nov 10 2020 | CYCN | Cyclerion Therapeu ... | Huyett William | Chief Financial Off ... | Sell | S | 2.52 | 3,827 | 9,644 | 67,590 | 71.4 K to 67.6 K (-5.36 %) |
| Nov 06 2020 | CYCN | Cyclerion Therapeu ... | Busch Andreas | Chief Innovation Of ... | Option Exercise | A | 2.48 | 75,000 | 186,000 | 75,000 | |
| Nov 06 2020 | CYCN | Cyclerion Therapeu ... | Busch Andreas | Chief Innovation Of ... | Option Exercise | A | 2.48 | 75,000 | 186,000 | 75,000 | |
| Jun 18 2020 | CYCN | Cyclerion Therapeu ... | Churchwell Kevin | Director | Option Exercise | A | 4.46 | 10,000 | 44,600 | 10,000 | |
| Jun 18 2020 | CYCN | Cyclerion Therapeu ... | CONRADES GEORGE H | Director | Option Exercise | A | 4.46 | 10,000 | 44,600 | 10,000 | |
| Jun 18 2020 | CYCN | Cyclerion Therapeu ... | Fanucci Marsha | Director | Option Exercise | A | 4.46 | 10,000 | 44,600 | 10,000 | |
| Jun 18 2020 | CYCN | Cyclerion Therapeu ... | Isacson Ole | Director | Option Exercise | A | 4.46 | 10,000 | 44,600 | 10,000 | |
| Jun 18 2020 | CYCN | Cyclerion Therapeu ... | Lovell Stephanie | Director | Option Exercise | A | 4.46 | 10,000 | 44,600 | 10,000 | |
| Jun 18 2020 | CYCN | Cyclerion Therapeu ... | MCGUIRE TERRANCE | Director | Option Exercise | A | 4.46 | 10,000 | 44,600 | 10,000 | |
| Jun 18 2020 | CYCN | Cyclerion Therapeu ... | Mendelsohn Michael | Director | Option Exercise | A | 4.46 | 10,000 | 44,600 | 10,000 | |
| Jun 18 2020 | CYCN | Cyclerion Therapeu ... | SCHULMAN AMY W | Director | Option Exercise | A | 4.46 | 10,000 | 44,600 | 10,000 | |
| Apr 02 2020 | CYCN | Cyclerion Therapeu ... | Hecht Peter M | Chief Executive Off ... | Option Exercise | A | 2.65 | 153,846 | 407,692 | 153,846 | |
| Feb 25 2020 | CYCN | Cyclerion Therapeu ... | Huyett William | Chief Financial Off ... | Sell | S | 5.12 | 3,559 | 18,222 | 71,417 | 75 K to 71.4 K (-4.75 %) |
| Dec 31 2019 | CYCN | Cyclerion Therapeu ... | Currie Mark G | President | Sell | S | 2.48 | 25,000 | 62,000 | 271,755 | 296.8 K to 271.8 K (-8.42 %) |
| Dec 31 2019 | CYCN | Cyclerion Therapeu ... | Currie Mark G | President | Sell | S | 2.55 | 25,000 | 63,750 | 296,755 | 321.8 K to 296.8 K (-7.77 %) |
| Nov 26 2019 | CYCN | Cyclerion Therapeu ... | Hecht Peter M | Chief Executive Off ... | Option Exercise | A | 2.01 | 75,000 | 150,750 | 75,000 | |
| Nov 26 2019 | CYCN | Cyclerion Therapeu ... | Currie Mark G | President | Option Exercise | A | 2.01 | 75,000 | 150,750 | 75,000 | |
| Nov 26 2019 | CYCN | Cyclerion Therapeu ... | Huyett William | Chief Financial Off ... | Option Exercise | A | 2.01 | 75,000 | 150,750 | 75,000 | |
| Nov 26 2019 | CYCN | Cyclerion Therapeu ... | Busch Andreas | Chief Innovation Of ... | Option Exercise | A | 2.01 | 75,000 | 150,750 | 75,000 | |
| Nov 19 2019 | CYCN | Cyclerion Therapeu ... | Busch Andreas | Chief Innovation Of ... | Buy | P | 1.82 | 125,000 | 227,500 | 125,000 | 0 to 125 K |
| Nov 12 2019 | CYCN | Cyclerion Therapeu ... | Huyett William | Chief Financial Off ... | Sell | S | 2.05 | 3,922 | 8,040 | 74,976 | 78.9 K to 75 K (-4.97 %) |
| Jul 12 2019 | CYCN | Cyclerion Therapeu ... | Hecht Peter M | Chief Executive Off ... | Option Exercise | M | 6.04 | 2,000 | 12,080 | 0 | |
| Jul 12 2019 | CYCN | Cyclerion Therapeu ... | Hecht Peter M | Chief Executive Off ... | Buy | M | 6.04 | 2,000 | 12,080 | 225,192 | 223.2 K to 225.2 K (+0.90 %) |
| Jun 04 2019 | CYCN | Cyclerion Therapeu ... | Mendelsohn Michael | Director | Option Exercise | A | 13.95 | 10,000 | 139,500 | 10,000 | |
| Jun 04 2019 | CYCN | Cyclerion Therapeu ... | MCGUIRE TERRANCE | Director | Option Exercise | A | 13.95 | 10,000 | 139,500 | 10,000 | |
| Jun 04 2019 | CYCN | Cyclerion Therapeu ... | Lovell Stephanie | Director | Option Exercise | A | 13.95 | 10,000 | 139,500 | 10,000 | |
| Jun 04 2019 | CYCN | Cyclerion Therapeu ... | Isacson Ole | Director | Option Exercise | A | 13.95 | 10,000 | 139,500 | 10,000 | |
| Jun 04 2019 | CYCN | Cyclerion Therapeu ... | Fanucci Marsha | Director | Option Exercise | A | 13.95 | 10,000 | 139,500 | 10,000 | |
| Jun 04 2019 | CYCN | Cyclerion Therapeu ... | CONRADES GEORGE H | Director | Option Exercise | A | 13.95 | 10,000 | 139,500 | 10,000 | |
| Jun 04 2019 | CYCN | Cyclerion Therapeu ... | Churchwell Kevin | Director | Option Exercise | A | 13.95 | 10,000 | 139,500 | 10,000 | |
| May 01 2019 | CYCN | Cyclerion Therapeu ... | Busch Andreas | Chief Innovation Of ... | Option Exercise | A | 15.40 | 300,000 | 4,620,000 | 300,000 | |
| Apr 10 2019 | CYCN | Cyclerion Therapeu ... | MCGUIRE TERRANCE | Director | Buy | P | 16.00 | 21,635 | 346,160 | 21,635 | 0 to 21.6 K |
| Apr 10 2019 | CYCN | Cyclerion Therapeu ... | MCGUIRE TERRANCE | Director | Buy | P | 16.00 | 604,482 | 9,671,712 | 604,482 | 0 to 604.5 K |
| Apr 10 2019 | CYCN | Cyclerion Therapeu ... | SCHULMAN AMY W | Director | Buy | P | 16.00 | 21,635 | 346,160 | 21,635 | 0 to 21.6 K |
| Apr 10 2019 | CYCN | Cyclerion Therapeu ... | SCHULMAN AMY W | Director | Buy | P | 16.00 | 604,482 | 9,671,712 | 604,482 | 0 to 604.5 K |
| Apr 03 2019 | CYCN | Cyclerion Therapeu ... | MCGUIRE TERRANCE | Director | Grant | A | 0.00 | 6,911 | 0 | 6,911 | 0 to 6.9 K |
| Apr 03 2019 | CYCN | Cyclerion Therapeu ... | MCGUIRE TERRANCE | Director | Grant | A | 0.00 | 162 | 0 | 162 | 0 to 162 |
| Apr 03 2019 | CYCN | Cyclerion Therapeu ... | MCGUIRE TERRANCE | Director | Grant | A | 0.00 | 3,279 | 0 | 3,279 | 0 to 3.3 K |
| Apr 03 2019 | CYCN | Cyclerion Therapeu ... | MCGUIRE TERRANCE | Director | Grant | A | 0.00 | 7,768 | 0 | 7,768 | 0 to 7.8 K |
| Apr 03 2019 | CYCN | Cyclerion Therapeu ... | Hecht Peter M | Chief Executive Off ... | Option Exercise | A | 14.20 | 857,977 | 12,183,273 | 857,977 | |
| Apr 03 2019 | CYCN | Cyclerion Therapeu ... | Hecht Peter M | Chief Executive Off ... | Option Exercise | A | 16.02 | 380,393 | 6,093,896 | 380,393 | |
| Apr 03 2019 | CYCN | Cyclerion Therapeu ... | Hecht Peter M | Chief Executive Off ... | Option Exercise | A | 18.46 | 344,829 | 6,365,543 | 344,829 | |
| Apr 03 2019 | CYCN | Cyclerion Therapeu ... | Hecht Peter M | Chief Executive Off ... | Option Exercise | A | 11.28 | 223,919 | 2,525,806 | 223,919 | |
| Apr 03 2019 | CYCN | Cyclerion Therapeu ... | Hecht Peter M | Chief Executive Off ... | Option Exercise | A | 17.20 | 56,500 | 971,800 | 56,500 | |
| Apr 03 2019 | CYCN | Cyclerion Therapeu ... | Hecht Peter M | Chief Executive Off ... | Option Exercise | A | 15.54 | 37,973 | 590,100 | 37,973 | |
| Apr 03 2019 | CYCN | Cyclerion Therapeu ... | Hecht Peter M | Chief Executive Off ... | Option Exercise | A | 14.40 | 43,680 | 628,992 | 43,680 | |
| Apr 03 2019 | CYCN | Cyclerion Therapeu ... | Hecht Peter M | Chief Executive Off ... | Option Exercise | A | 16.21 | 36,089 | 585,003 | 36,089 | |
| Apr 03 2019 | CYCN | Cyclerion Therapeu ... | Hecht Peter M | Chief Executive Off ... | Option Exercise | A | 12.23 | 53,090 | 649,291 | 53,090 | |
| Apr 03 2019 | CYCN | Cyclerion Therapeu ... | Hecht Peter M | Chief Executive Off ... | Option Exercise | A | 12.39 | 12,499 | 154,863 | 12,499 | |
| Apr 03 2019 | CYCN | Cyclerion Therapeu ... | Hecht Peter M | Chief Executive Off ... | Option Exercise | A | 6.04 | 2,000 | 12,080 | 2,000 | |
| Apr 03 2019 | CYCN | Cyclerion Therapeu ... | Hecht Peter M | Chief Executive Off ... | Grant | A | 0.00 | 485 | 0 | 485 | 0 to 485 |
| Apr 03 2019 | CYCN | Cyclerion Therapeu ... | Hecht Peter M | Chief Executive Off ... | Grant | A | 0.00 | 485 | 0 | 485 | 0 to 485 |
| Apr 03 2019 | CYCN | Cyclerion Therapeu ... | Hecht Peter M | Chief Executive Off ... | Grant | A | 0.00 | 485 | 0 | 485 | 0 to 485 |
| Apr 03 2019 | CYCN | Cyclerion Therapeu ... | Hecht Peter M | Chief Executive Off ... | Grant | A | 0.00 | 223,192 | 0 | 223,192 | 0 to 223.2 K |
| Apr 03 2019 | CYCN | Cyclerion Therapeu ... | Currie Mark G | President | Option Exercise | A | 14.20 | 514,786 | 7,309,961 | 514,786 | |
| Apr 03 2019 | CYCN | Cyclerion Therapeu ... | Currie Mark G | President | Option Exercise | A | 16.02 | 141,007 | 2,258,932 | 141,007 | |
| Apr 03 2019 | CYCN | Cyclerion Therapeu ... | Currie Mark G | President | Option Exercise | A | 18.46 | 113,430 | 2,093,918 | 113,430 | |
| Apr 03 2019 | CYCN | Cyclerion Therapeu ... | Currie Mark G | President | Option Exercise | A | 11.28 | 50,801 | 573,035 | 50,801 | |
| Apr 03 2019 | CYCN | Cyclerion Therapeu ... | Currie Mark G | President | Option Exercise | A | 17.20 | 2,500 | 43,000 | 2,500 | |
| Apr 03 2019 | CYCN | Cyclerion Therapeu ... | Currie Mark G | President | Option Exercise | A | 17.20 | 13,125 | 225,750 | 13,125 | |
| Apr 03 2019 | CYCN | Cyclerion Therapeu ... | Currie Mark G | President | Option Exercise | A | 15.54 | 9,930 | 154,312 | 9,930 | |
| Apr 03 2019 | CYCN | Cyclerion Therapeu ... | Currie Mark G | President | Option Exercise | A | 14.40 | 27,773 | 399,931 | 27,773 | |
| Apr 03 2019 | CYCN | Cyclerion Therapeu ... | Currie Mark G | President | Option Exercise | A | 16.21 | 17,491 | 283,529 | 17,491 | |
| Apr 03 2019 | CYCN | Cyclerion Therapeu ... | Currie Mark G | President | Option Exercise | A | 12.23 | 37,286 | 456,008 | 37,286 | |
| Apr 03 2019 | CYCN | Cyclerion Therapeu ... | Currie Mark G | President | Option Exercise | A | 12.39 | 888 | 11,002 | 888 | |
| Apr 03 2019 | CYCN | Cyclerion Therapeu ... | Currie Mark G | President | Buy | P | 14.81 | 270,107 | 4,000,285 | 321,755 | 51.6 K to 321.8 K (+522.98 %) |
| Apr 03 2019 | CYCN | Cyclerion Therapeu ... | Currie Mark G | President | Grant | A | 0.00 | 51,648 | 0 | 51,648 | 0 to 51.6 K |
| Apr 03 2019 | CYCN | Cyclerion Therapeu ... | Huyett William | Chief Financial Off ... | Option Exercise | A | 14.20 | 222,002 | 3,152,428 | 222,002 | |
| Apr 03 2019 | CYCN | Cyclerion Therapeu ... | Huyett William | Chief Financial Off ... | Option Exercise | A | 16.81 | 221,349 | 3,720,877 | 221,349 | |
| Apr 03 2019 | CYCN | Cyclerion Therapeu ... | Huyett William | Chief Financial Off ... | Grant | A | 0.00 | 39,179 | 0 | 78,912 | 39.7 K to 78.9 K (+98.61 %) |
| Apr 03 2019 | CYCN | Cyclerion Therapeu ... | Huyett William | Chief Financial Off ... | Grant | A | 0.00 | 38,327 | 0 | 38,327 | 0 to 38.3 K |
| Apr 03 2019 | CYCN | Cyclerion Therapeu ... | SCHULMAN AMY W | Director | Grant | A | 0.00 | 3,279 | 0 | 7,508 | 4.2 K to 7.5 K (+77.54 %) |
| Apr 03 2019 | CYCN | Cyclerion Therapeu ... | SCHULMAN AMY W | Director | Grant | A | 0.00 | 4,229 | 0 | 4,229 | 0 to 4.2 K |
| Apr 03 2019 | CYCN | Cyclerion Therapeu ... | Fanucci Marsha | Director | Grant | A | 0.00 | 3,279 | 0 | 16,950 | 13.7 K to 17 K (+23.99 %) |
| Apr 03 2019 | CYCN | Cyclerion Therapeu ... | Fanucci Marsha | Director | Grant | A | 0.00 | 13,671 | 0 | 13,671 | 0 to 13.7 K |
| Apr 03 2019 | CYCN | Cyclerion Therapeu ... | Mendelsohn Michael | Director | Grant | A | 0.00 | 2,421 | 0 | 2,421 | 0 to 2.4 K |
| Apr 03 2019 | CYCN | Cyclerion Therapeu ... | Lovell Stephanie | Director | Grant | A | 0.00 | 2,421 | 0 | 2,421 | 0 to 2.4 K |
| Apr 03 2019 | CYCN | Cyclerion Therapeu ... | Isacson Ole | Director | Grant | A | 0.00 | 2,421 | 0 | 2,421 | 0 to 2.4 K |
| Apr 03 2019 | CYCN | Cyclerion Therapeu ... | CONRADES GEORGE H | Director | Grant | A | 0.00 | 2,421 | 0 | 2,421 | 0 to 2.4 K |
| Apr 03 2019 | CYCN | Cyclerion Therapeu ... | Churchwell Kevin | Director | Grant | A | 0.00 | 2,421 | 0 | 2,421 | 0 to 2.4 K |
| Apr 02 2019 | CYCN | Cyclerion Therapeu ... | IRONWOOD PHARMACEUTICALS INC | 10% Owner | Sell | J | 0.00 | 15,562,555 | 0 | 0 | 15.6 M to 0 (-100.00 %) |
| Apr 02 2019 | CYCN | Cyclerion Therapeu ... | IRONWOOD PHARMACEUTICALS INC | 10% Owner | Grant | A | 0.00 | 15,562,455 | 0 | 15,562,555 | 100 to 15.6 M (+15,562,455.00 %) |
Page: 1